A multicentre randomised trial comparing the efficacy and safety of Remogen® Omega versus Cationorm® in the treatment of patients suffering from dry eye

Purpose Remogen® Omega is the first omega‐3 containing drop indicated in the treatment of dry eye syndrome (DES). It contributes to the maintenance of the physicochemical balance of the tear film and facilitates eye recovery. The aim of this study was to compare the efficacy and safety of Remogen® O...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta ophthalmologica (Oxford, England) England), 2022-01, Vol.100 (S267), p.n/a
Hauptverfasser: Pisella, Pierre‐Jean, Marsousi, Niloufar, Doan, Serge, Douat, Julien, Girard, Brigitte, Cochener, Béatrice, Christophe, Baudouin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!